ZeroG TRIP: Training Responses in Postural Rehabilitation
ZeroG TRIP: Training Responses in Postural Rehabilitation
批准号:
9345110
负责人:
Joseph M. Hidler
金额:
$22.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2019-08-31
关键词:
Adverse eventAgeAgingAlgorithmsBalance trainingBody WeightCharacteristicsClinicalComputersDevelopmentDevicesElderlyEquilibriumFeedbackGaitGait abnormalityGait speedGoalsImpairmentIndividualInjuryIntuitionLaboratoriesLaboratory StudyManualsMovementNeurologicParkinson DiseasePatientsPhasePostureQuality of lifeQuestionnairesRecruitment ActivityRehabilitation therapyResearch PersonnelRoboticsSafetySmall Business Innovation Research GrantSystemTabletsTechnologyTestingTrainingTranslatingVirginiaWalkingWireless TechnologyWorkbaseclinical practicedisabilityequilibration disorderexperiencefall riskfallsflexibilitygait rehabilitationhigh riskimprovedinnovationinstrumentationnervous system disorderphysical therapistpreventprototyperehabilitation technologyresearch clinical testingresponsesafety practicesensortouchscreenusability
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The goal of this project is to significantly enhance our understanding and treatment of inadequate balance
responses in the elderly and in patients with neurological impairments following external perturbations such as
a slip or trip. Our laboratory studies have shown that balance responses can be improved with practice in the
elderly and in patients with Parkinson's disease (PD). However, these laboratory studies have not been
translated into clinical practice because there is currently no safe and reliable technology for training and
quantifying balance responses, particularly during overground walking. The ZeroG gait and balance training
system developed and now commercialized by Aretech, LLC (Ashburn, VA) allows individuals with gait and
balance disorders to safety practice walking overground with concurrent body-weight support and fall
protection. The current system does not allow patients to practice recovering from unexpected external
perturbation for balance training nor does the system contain the necessary instrumentation for quantifying
balance responses.
In this Phase I SBIR, we will significantly enhance the capabilities of the ZeroG system by developing
controlled balance perturbations of adjustable magnitude and direction that can be delivered during standing
and overground walking. The framework for the ZeroG balance perturbation sequences, called TRIP (Train
Responses in Postural Rehabilitation), will be based upon the scientific findings of our laboratory over the last
decade. We will develop the specific perturbation characteristics needed to train postural stepping responses
in people with balance deficits due to PD and work closely with physical therapists on usability and safety.
Finally, we will determine the feasibility and clinical usability of the ZeroG TRIP system through questionnaire
feedback from patients and therapists.
Phase II of this SBIR will focus on additional technical development of the ZeroG TRIP system and subsequent
clinical testing of the device. Specifically, we plan to develop and test innovative metrics of postural stepping
responses for ZeroG TRIP using the body-worn sensors with the partnership between Aretech, LLC and
APDM, Inc. We will also utilize the APDM sensors to track the patient's movements throughout the gait cycle
so that we can automatically trigger the TRIP perturbation rather than having to manually trigger the
perturbation. Finally, we will refine the user interfaces on both the touch screen computer and wireless tablet,
making the controls intuitive for the user yet providing sufficient flexibility to control the perturbation sequences.
The clinical testing during Phase II will focus on comparing improvements in balance responses and balance
confidence after training with TRIP compared to ZeroG body-weight support walking in people with PD.
The ZeroG TRIP system will enable physical therapists to safely and systematically assess and treat
inadequate balance responses, which are a major contributor to falls, disability, and declining quality of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ZeroG: Dynamic over-ground body-weight support system
-
批准号:8058926
-
项目类别:
-
资助金额:$40.75万
-
财政年份:2009
-
负责人:Joseph M. Hidler
-
依托单位:
ZeroG: Dynamic over-ground body-weight support system
-
批准号:8250385
-
项目类别:
-
资助金额:$40.9万
-
财政年份:2009
-
负责人:Joseph M. Hidler
-
依托单位:
ZeroG: Dynamic Over-Ground Body-Weight Support System
-
批准号:7671064
-
项目类别:
-
资助金额:$14.12万
-
财政年份:2009
-
负责人:Joseph M. Hidler
-
依托单位:
PREDOCTORAL FELLOWSHIP PROGRAM (DISABILITY)
-
批准号:2888780
-
项目类别:
-
资助金额:$1.91万
-
财政年份:1999
-
负责人:Joseph M. Hidler
-
依托单位:
PREDOCTORAL FELLOWSHIP PROGRAM (DISABILITY)
-
批准号:2673396
-
项目类别:
-
资助金额:$1.61万
-
财政年份:1998
-
负责人:Joseph M. Hidler
-
依托单位:
PREDOCTORAL FELLOWSHIP PROGRAM (DISABILITY)
-
批准号:2196575
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1997
-
负责人:Joseph M. Hidler
-
依托单位:
PREDOCTORAL FELLOWSHIP PROGRAM (DISABILITY)
-
批准号:2761338
-
项目类别:
-
资助金额:$0.49万
-
财政年份:1997
-
负责人:Joseph M. Hidler
-
依托单位:
PREDOCTORAL FELLOWSHIP PROGRAM (DISABILITY)
-
批准号:2519094
-
项目类别:
-
资助金额:$1.35万
-
财政年份:1997
-
负责人:Joseph M. Hidler
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: